山东潍坊地区汉族人群对氧磷酶Q192R基因多态性与冠心病的相关性的研究(3)
 |
| 第1页 |
参见附件(1787KB，3页)。
参 考 文 献
[1] Kitchen B J,Master C J,Winzor D J.Effects of lipid removal on the molecular size and kinetic properties of bovine plasma arylestesterase.Bioc he m,1973,135:93-99.
[2] 杜传书.医学遗传学基础.人民卫生出版社,1995.
[3] Mackness M I,Mackkness B,Durrington P N.Paraoxonase and coronary heart disease.Atheroscler Suppl,2002,3(4):4955.
[4] Mackness M I,Mackness B,Durington P N,et al.Paraoxonase and coronary heart disease.CurrOpinLipidol,1998,9(4):319.
[5] Ilia Leview,Alberto Righetti,Richard W,James,et al.Paraoxonase promoter polymorphisms T(-107)C and relative paraoxonase deficiency as determinants of risk of coronary heart disease.Mol Med,2001,79:457-463.
[6]Sagmez B, Demirsoy E, Yagan N, et al.Frequency of paraoxonose 192/55 Polymorphism in an Iranian population. Toxicol Environ Health A,2007,70(13):1125-1129.
[7] Shih D M,Gul,Xia Y R,et al.Micelacking serum paraoxonase are susceptible to orangnohosphatet oxicity and atherosclerosis.Nature,1998,394:284-287.
[8] Twakura A, Shastry S,Luedemann C,et al.TagSNP analyses of the Pon gene cluster. Effects on Pon1 activity.LDL.Oxidative J lipid.Res,2006 May, 47(5):1014-1024.
[9] Siner R,Dotyc I.The correlation of paraoxonose(Pon1) activity with lipid and lipoprotein levels differs with vascular disease status.J lipid.Res,2005,46(9):1888-1895.
[10] Colhoun H M,McKeigue P M,Davey Smith G.Problems.of reporting genetic associations with complex outcomes: can we avoid being swamped by spurious findings.Lancet,2003,361:865-872.
您现在查看是摘要介绍页，详见PDF附件(1787KB，3页)。